C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2695070
The present invention provides a biomarker SFRS7 which is predictive for the clinical benefit of EGFR inhibitor treatment in cancer patients.
La présente invention concerne un biomarqueur SFRS7 qui est prédictif du bénéfice clinique d'un traitement inhibiteur d'EGFR chez des patients cancéreux.
Delmar Paul
Klughammer Barbara
Lutz Verena
Mcloughlin Patricia
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Predictive marker for egfr inhibitor treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Predictive marker for egfr inhibitor treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predictive marker for egfr inhibitor treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1427430